Nuclear envelope proteins and associated diseases

Curr Opin Neurol. 2000 Oct;13(5):533-9. doi: 10.1097/00019052-200010000-00005.


There is a growing body of evidence in favour of the presence of human diseases caused by mutations in genes that encode the nuclear envelope proteins emerin and lamin A/C (lamin A and C are alternatively spliced variants of the same gene). Emerin deficiency results in X-linked Emery-Dreifuss muscular dystrophy (EDMD). Lamin A/C mutations cause the autosomal-dominant form of EDMD, limb-girdle muscular dystrophy with atrioventricular conduction disturbances (type 1B), hypertrophic cardiomyopathy and Dunnigan-type familial partial lipodystrophy. In the targeted mouse model of lamin A gene deficiency, loss of lamin A/C is associated with mislocalization of emerin. Thus, one plausible pathomechanism for EDMD, limb-girdle muscular dystrophy type 1B, hypertrophic cardiomyopathy and familial partial lipodystrophy is the presence of specific abnormalities of the nuclear envelope. Therefore, a group of markedly heterogeneous disorders can be classified as 'nuclear envelopathies'. The present review summarizes recent findings on nuclear envelope proteins and diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiomyopathy, Hypertrophic / genetics
  • Disease Models, Animal
  • Humans
  • Lipodystrophy / genetics
  • Muscular Dystrophy, Emery-Dreifuss / genetics
  • Mutation*
  • Neuromuscular Diseases / genetics*
  • Nuclear Envelope / genetics*
  • Nuclear Proteins / genetics*


  • Nuclear Proteins